Infectious Diseases

502 questions

Question 101Question →

Match each clinical exposure scenario with the most appropriate post-exposure prophylaxis or initial preventive management strategy.

Click a left item, then click its matching right item

Items

Healthcare worker with no prior vaccination sustains a needlestick injury from a patient who is HBsAg-positive.
College student who shared a dormitory room with a peer recently diagnosed with Neisseria meningitidis meningitis.
Camper who awakens to find a bat in their tent but has no visible bite marks.
Hiker in the northeastern United States who removes an engorged Ixodes scapularis tick that was attached for approximately 48 hours.

Matches

Show answer & explanation

Answer

Each specific exposure scenario must be matched with its guideline-directed post-exposure prophylaxis regimen.
Each exposure scenario carries a specific pathogen risk that mandates a targeted prophylactic strategy. Needlestick exposure to Hepatitis B in an unvaccinated host requires both passive (HBIG) and active (vaccine) immunity. Meningococcal meningitis close contacts need short-course antibiotics like ciprofloxacin to clear nasopharyngeal carriage. Bat exposures, due to the subtle nature of their bites and the fatal outcome of rabies, require both RIG and rabies vaccine. Finally, an Ixodes tick attached for greater than 36 hours in an endemic area meets the criteria for a single prophylactic dose of doxycycline.

Step-by-Step Solution

1
Analyze each clinical exposure scenario to determine the primary infectious pathogen risk.
Pathogens identified include Hepatitis B virus, Neisseria meningitidis, Rabies virus, and Borrelia burgdorferi.
Correct pathogen identification is essential for selecting the targeted prophylactic agent.
2
Recall the current evidence-based post-exposure prophylaxis protocol for each specific pathogen.
HBV requires HBIG and vaccine; Meningococcus requires ciprofloxacin/rifampin/ceftriaxone; Rabies requires RIG and vaccine; Lyme requires single-dose doxycycline.
Prophylactic strategies differ significantly, ranging from single-dose antibiotics to combination passive and active immunizations.
3
Match the clinical scenario to the appropriate prophylactic regimen.
The exact therapeutic matches are established for all four clinical scenarios.
This completes the required assessment task.

Key Concept

Post-exposure prophylaxis (PEP) protocols for common infectious disease exposures
Question 102Question →

An 82-year-old male resident of a skilled nursing facility is brought to the outpatient clinic for a routine follow-up appointment. His medical history is significant for benign prostatic hyperplasia, type 2 diabetes mellitus, and vascular dementia. The patient relies on a chronic indwelling urinary catheter due to refractory urinary retention. His caregiver reports that he has been at his baseline mental and physical status, eating well, and participating in daily activities without issue. The patient denies any fever, chills, flank pain, or suprapubic discomfort. Vital signs are temperature 37.1°C (98.8°F), blood pressure 130/80 mmHg, pulse 78/min, and respiratory rate 14/min. Physical examination reveals a soft, non-tender abdomen and no costovertebral angle tenderness. As part of a recent facility protocol, a routine urinalysis was performed yesterday which showed 50 white blood cells per high-power field, positive leukocyte esterase, and positive nitrites. Today, the urine culture results return showing >10^5 CFU/mL of multidrug-resistant Pseudomonas aeruginosa. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Provide reassurance and observation without antibiotic therapy

Answer

The most appropriate management is to provide reassurance and observation without antibiotic therapy, as the patient has asymptomatic bacteriuria.
The correct management for this patient is reassurance and observation without antibiotic therapy. This patient has a chronic indwelling urinary catheter and presents with a positive urinalysis and urine culture but no clinical symptoms of infection (e.g., fever, altered mental status, flank pain, or hemodynamic instability). This clinical picture represents asymptomatic bacteriuria. In patients with chronic catheters, bacteriuria and pyuria are virtually ubiquitous and reflect colonization rather than active tissue invasion. According to infectious disease guidelines, screening for and treating asymptomatic bacteriuria is contraindicated in this population, regardless of the organism isolated or its resistance profile. Unnecessary antibiotic treatment in these cases provides no clinical benefit and actively harms the patient by promoting the emergence of highly resistant pathogens (such as the multidrug-resistant Pseudomonas seen here) and increasing the risk of adverse drug events, including Clostridioides difficile infection.

Step-by-Step Solution

1
Assess the patient's clinical symptoms and vital signs.
The patient is asymptomatic, at his baseline mental status, and hemodynamically stable without fever or localizing genitourinary signs.
Differentiating between symptomatic urinary tract infection (UTI) and asymptomatic bacteriuria relies primarily on the presence of clinical symptoms.
2
Evaluate the laboratory findings in the context of the clinical picture.
The urinalysis shows pyuria and the culture is positive for Pseudomonas aeruginosa, but these findings occur in the absence of symptoms.
Pyuria and bacteriuria are expected findings in nearly all patients with chronic indwelling urinary catheters and do not independently diagnose a UTI.
3
Determine the indication for antibiotic therapy.
No antibiotics are indicated. The patient requires only reassurance and observation.
Guidelines explicitly recommend against screening for or treating asymptomatic bacteriuria in patients with chronic indwelling catheters to prevent the development of multidrug-resistant organisms.

Key Concept

Patients with chronic indwelling urinary catheters universally develop bacteriuria and pyuria; in the absence of systemic or localizing symptoms, this represents asymptomatic bacteriuria and should not be treated with antibiotics.
Estimated Time:1m 0s
Question 103Question →

An 82-year-old woman is evaluated in her long-term care facility for a 1-day history of acute confusion and agitation. She has a history of advanced Alzheimer dementia, hypertension, and osteoarthritis. According to the nursing staff, she has been combative during morning care and is disoriented to place, which represents a significant change from her baseline behavior. She has not exhibited any cough, vomiting, or diarrhea. Vital signs are temperature 37.1°C (98.8°F), blood pressure 138/86 mm Hg, pulse 82/min, and respirations 14/min. Physical examination shows dry mucous membranes and decreased skin turgor. Cardiopulmonary examination is unremarkable. The abdomen is soft and non-tender; there is no suprapubic or costovertebral angle tenderness.

Laboratory results:
Serum sodium: 149 mEq/L
Blood urea nitrogen: 38 mg/dL
Serum creatinine: 1.3 mg/dL (baseline: 0.9 mg/dL)

Urinalysis:
Color: Cloudy yellow
Leukocyte esterase: Positive
Nitrites: Positive
White blood cells: 25/hpf
Bacteria: Numerous

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Evaluate for alternative causes of altered mental status

Answer

The most appropriate next step is to evaluate for alternative causes of altered mental status, such as dehydration.
The correct answer is to evaluate for alternative causes of altered mental status. This patient presents with acute delirium and an abnormal urinalysis, but she completely lacks systemic signs of infection (e.g., fever, tachycardia, hemodynamic instability) and localizing genitourinary symptoms (e.g., suprapubic or flank pain). This clinical picture is characteristic of asymptomatic bacteriuria (ASB), which is present in up to 50% of elderly women residing in long-term care facilities. Current Infectious Diseases Society of America (IDSA) guidelines strongly recommend against screening for or treating ASB in older adults with delirium in the absence of systemic signs of infection. In this patient population, acute confusion is frequently driven by non-infectious etiologies. The patient's physical examination and laboratory results (dry mucous membranes, decreased skin turgor, hypernatremia, and an elevated BUN/creatinine ratio) clearly point to severe dehydration as the underlying cause of her delirium. Treating her abnormal urinalysis with antibiotics will not improve her mental status and will expose her to unnecessary risks, including adverse drug effects, Clostridioides difficile infection, and the promotion of antimicrobial resistance. The appropriate step is to withhold antibiotics and manage the true underlying cause of her condition by providing hydration.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and vital signs.
The patient has acute delirium and signs of significant volume depletion (dry mucous membranes, hypernatremia, elevated BUN/creatinine ratio). She does not have a fever, tachycardia, hypotension, or localized urinary tract symptoms.
Establishing the clinical syndrome and identifying systemic signs of infection is critical to differentiate true infection from other causes of altered mental status.
2
Interpret the urinalysis in the context of the patient's demographics.
The urinalysis is positive for leukocyte esterase, nitrites, and bacteria. However, without localizing symptoms or systemic signs of infection, this represents asymptomatic bacteriuria (ASB).
ASB is highly prevalent in long-term care residents (up to 50% of women) and does not inherently cause systemic symptoms or delirium.
3
Apply guidelines for antibiotic stewardship in this population.
Guidelines strongly recommend against screening for or treating ASB in elderly patients with delirium unless there are systemic signs of infection or local genitourinary symptoms.
Treating ASB does not improve delirium, but it increases the risk of adverse drug events, Clostridioides difficile infection, and antimicrobial resistance.

Key Concept

In older patients with cognitive impairment who present with delirium and a positive urinalysis, antimicrobial treatment is contraindicated unless there are systemic signs of infection or localizing genitourinary symptoms. The underlying non-infectious cause of delirium must be addressed.
Question 104Question →

Match each clinical presentation of an immunocompromised patient with HIV to the most appropriate initial targeted antimicrobial regimen.

Click a left item, then click its matching right item

Items

A 32-year-old man with a CD4 count of 45 cells/mm³ presenting with decreased visual acuity, floaters, and yellow-white retinal exudates with associated hemorrhage.
A 45-year-old man with a CD4 count of 90 cells/mm³ presenting with new-onset seizures, focal left-sided weakness, and multiple ring-enhancing lesions with surrounding edema on brain MRI.
A 35-year-old man with a CD4 count of 150 cells/mm³ presenting with a 3-week history of dry cough, exertional dyspnea, hypoxemia, and bilateral ground-glass opacities on high-resolution chest CT.
A 38-year-old man with a CD4 count of 80 cells/mm³ presenting with subacute headache, fever, lethargy, and cerebrospinal fluid analysis showing an elevated opening pressure and encapsulated yeast on India ink stain.

Matches

Show answer & explanation

Answer

Cytomegalovirus retinitis is treated with valganciclovir. Toxoplasma encephalitis is treated with sulfadiazine, pyrimethamine, and leucovorin. Pneumocystis jirovecii pneumonia is treated with trimethoprim-sulfamethoxazole. Cryptococcal meningitis is treated with amphotericin B and flucytosine.
Each clinical scenario correctly aligns a classic opportunistic infection presentation with its established first-line therapeutic regimen. CMV retinitis is managed with valganciclovir. Toxoplasmosis requires sulfadiazine and pyrimethamine. PCP is effectively treated with high-dose trimethoprim-sulfamethoxazole. Cryptococcal meningitis induction mandates amphotericin B and flucytosine.

Step-by-Step Solution

1
Analyze the CD4 count and specific clinical manifestations for each patient to identify the underlying opportunistic pathogen.
Pathogens identified: Cytomegalovirus, Toxoplasma gondii, Pneumocystis jirovecii, and Cryptococcus neoformans.
Accurate identification of the specific opportunistic infection is an essential prerequisite for selecting the appropriate targeted antimicrobial therapy.
2
Determine the guideline-directed first-line pharmacological treatment for each identified infection.
Matched therapies: Valganciclovir for CMV; Sulfadiazine/pyrimethamine/leucovorin for Toxoplasma; TMP-SMX for PCP; Amphotericin B/flucytosine for Cryptococcus.
Standard of care requires these specific regimens to maximize efficacy, ensure CNS penetration where necessary, and minimize disease progression.
3
Pair each clinical vignette with its corresponding treatment regimen.
All four clinical presentations are successfully matched to their respective first-line therapies.
To synthesize the clinical diagnostic findings with the correct pharmacological management.

Key Concept

Targeted treatment of opportunistic infections in HIV/AIDS based on characteristic clinical presentations and specific CD4 count thresholds.
Question 105Question →

A critical care physician is reviewing the microbiological data for a patient admitted with a severe burn injury. One week into the hospitalization, the patient developed a new-onset fever of 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}) and hypotension requiring vasopressor support. Blood cultures were obtained from a central venous catheter and a peripheral vein, and empiric antimicrobial therapy with intravenous vancomycin, cefepime, and gentamicin was instituted.

Today, both sets of blood cultures are positive for *Klebsiella pneumoniae*. The microbiology laboratory reports that the isolate is susceptible to ceftriaxone, cefepime, piperacillin-tazobactam, and meropenem, but resistant to ampicillin. The patient's clinical status has stabilized significantly; the fever has resolved, and vasopressor support was discontinued yesterday. Based on the principles of antimicrobial stewardship, which of the following is the most appropriate modification to this patient's pharmacologic regimen?

Show answer & explanation

Answer: Discontinue all current antibiotics and initiate intravenous ceftriaxone

Answer

The most appropriate next step is to discontinue the broad-spectrum empiric regimen (vancomycin, cefepime, and gentamicin) and transition to intravenous ceftriaxone, which provides targeted, narrow-spectrum coverage for the susceptible pathogen.
This patient's blood cultures have finalized, revealing *Klebsiella pneumoniae*. Susceptibility testing indicates the organism is vulnerable to ceftriaxone, a third-generation cephalosporin. Once a pathogen is identified and susceptibilities are known, the core principle of antimicrobial stewardship dictates de-escalating from empiric broad-spectrum therapy to a targeted, narrower-spectrum agent. Ceftriaxone is highly efficacious for susceptible *Klebsiella* bacteremia, possesses a favorable side-effect profile, and lacks anti-pseudomonal activity, making it the ideal narrow-spectrum choice to replace the unnecessarily broad vancomycin, cefepime, and gentamicin regimen.

Step-by-Step Solution

1
Identify the infecting pathogen and its susceptibilities.
The patient has a bloodstream infection caused by Klebsiella pneumoniae that is susceptible to ceftriaxone, among other broader-spectrum agents.
Pathogen identification and susceptibility testing are required to transition from empiric to definitive therapy.
2
Evaluate the current empiric antibiotic regimen.
The patient is receiving vancomycin (anti-MRSA), cefepime (anti-pseudomonal), and gentamicin (additional Gram-negative coverage), which was appropriate empirically for a critically ill burn patient.
Empiric therapy must cover likely resistant organisms until cultures finalize and the patient stabilizes.
3
Apply antimicrobial stewardship principles to select definitive therapy.
Therapy should be de-escalated by discontinuing unnecessary MRSA and pseudomonal coverage. Ceftriaxone provides the narrowest effective coverage for this specific isolate.
De-escalation minimizes toxicity (e.g., nephrotoxicity from vancomycin and gentamicin) and prevents the emergence of antimicrobial resistance.

Key Concept

In patients with culture-confirmed Gram-negative bacteremia, empiric broad-spectrum antimicrobial therapy should be de-escalated to the narrowest-spectrum agent demonstrated to be effective by susceptibility testing (e.g., a third-generation cephalosporin for susceptible Enterobacteriaceae).
Question 106Question →

A 72-year-old man is evaluated on hospital day 3 for discharge planning. He was initially admitted with fever, productive cough, and left-sided pleuritic chest pain. Chest radiography on admission demonstrated a dense left lower lobe consolidation. He was started on empiric intravenous ceftriaxone and azithromycin. Two sets of blood cultures drawn upon presentation have grown *Streptococcus pneumoniae*. Antimicrobial susceptibility testing is reported as follows:

AntimicrobialInterpretationMIC (µg/mL)
PenicillinSusceptible0.03
CeftriaxoneSusceptible0.25
ErythromycinResistant>8.0
LevofloxacinSusceptible1.0
VancomycinSusceptible0.5

The patient's clinical status has markedly improved. He has been afebrile for 24 hours, maintains an oxygen saturation of 96% on room air, and is tolerating an oral diet. His medical history includes hypertension and benign prostatic hyperplasia. He has no known drug allergies. The plan is to discharge the patient to complete a total 7-day course of antibiotics at home. Which of the following is the most appropriate oral antibiotic to prescribe for discharge?

Show answer & explanation

Answer: Amoxicillin

Answer

Amoxicillin
The patient has community-acquired pneumonia with *Streptococcus pneumoniae* bacteremia. Having achieved clinical stability (afebrile, no oxygen requirement, tolerating oral intake), he is eligible for oral step-down therapy. The susceptibility panel shows the isolate is highly susceptible to penicillin. For penicillin-susceptible *S. pneumoniae*, oral amoxicillin is the drug of choice due to its targeted narrow spectrum, excellent oral bioavailability, and high efficacy in pulmonary tissues. The presence of bacteremia does not require a broader-spectrum agent or an extended intravenous course once the patient demonstrates clinical improvement.

Step-by-Step Solution

1
Identify the primary diagnosis and the patient's current clinical trajectory.
The patient has community-acquired pneumonia with concurrent pneumococcal bacteremia, but is now clinically stable and ready for step-down therapy.
Establishing clinical stability confirms that an oral transition is safe, regardless of initial bacteremia.
2
Analyze the antimicrobial susceptibility data.
The *S. pneumoniae* isolate is highly susceptible to penicillin (MIC 0.03 µg/mL).
Specific MIC values guide the selection of the narrowest effective agent.
3
Recall the resistance mechanism of Streptococcus pneumoniae.
Resistance is mediated by altered penicillin-binding proteins (PBPs), not by beta-lactamase production.
This pathophysiologic mechanism dictates whether a beta-lactamase inhibitor (like clavulanate) is clinically useful.
4
Select the optimal narrow-spectrum oral agent.
Amoxicillin is chosen over amoxicillin-clavulanate, cephalosporins, and fluoroquinolones.
Amoxicillin provides excellent oral bioavailability and targeted coverage without unnecessary ecological disruption.

Key Concept

Oral step-down therapy for susceptible Streptococcus pneumoniae bacteremia and mechanisms of beta-lactam resistance.
Estimated Time:1m 15s
Question 107Question →

A first-year internal medicine resident sustains a deep, bleeding needlestick injury to their index finger while drawing arterial blood from a patient with known, poorly controlled HIV infection. Arrange the following steps in the most appropriate chronological sequence for managing this occupational exposure.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Wash the puncture site, 2) Report the incident to occupational health, 3) Draw baseline blood for serology, and 4) Initiate the post-exposure prophylaxis regimen.
The standard sequence for managing an occupational exposure to bloodborne pathogens begins with immediate local first aid (washing with soap and water) to reduce the viral inoculum. This is followed by reporting the incident to occupational health to activate institutional protocols. Next, baseline serology and safety labs are drawn from the exposed healthcare worker. Finally, a three-drug antiretroviral PEP regimen is initiated as soon as possible, ideally within 1 to 2 hours of the exposure.

Step-by-Step Solution

1
Perform immediate local first aid.
The puncture site is washed with soap and water.
Physical removal of blood and bodily fluids reduces the viral inoculum and risk of transmission. This must be done immediately.
2
Activate the exposure protocol.
The incident is reported to occupational health or the designated emergency personnel.
Institutional protocols ensure standardized testing, proper documentation, and immediate access to prophylactic antiretroviral medications.
3
Perform baseline evaluation.
Baseline HIV, HBV, and HCV serologies, along with safety labs, are drawn from the exposed resident.
Baseline testing is necessary to document the worker's pre-existing infectious status and organ function before starting potentially toxic PEP medications.
4
Administer empiric therapy.
A three-drug antiretroviral post-exposure prophylaxis (PEP) regimen is initiated.
PEP is most effective when started as soon as possible, ideally within 1-2 hours of the exposure. It should not be delayed while awaiting lab results.

Key Concept

Occupational HIV exposure management sequence
Estimated Time:1m 0s
Question 108Question →

Match each patient's clinical presentation and cerebrospinal fluid (CSF) analysis findings with the most appropriate targeted or empiric treatment regimen.

Click a left item, then click its matching right item

Items

A 22-year-old college student presents with fever, severe headache, nuchal rigidity, and a petechial rash. CSF reveals 1200 WBCs/µL (90% neutrophils), glucose 25 mg/dL, and protein 150 mg/dL.
A 65-year-old man presents with acute fever, confusion, and new-onset focal seizures. CSF reveals 150 WBCs/µL (95% lymphocytes), glucose 65 mg/dL, protein 80 mg/dL, and numerous erythrocytes.
A 45-year-old woman with advanced HIV (CD4 count = 30 cells/mm³) presents with subacute headache and lethargy. CSF reveals an opening pressure of 350 mm H2O, 50 WBCs/µL (90% lymphocytes), glucose 30 mg/dL, and protein 100 mg/dL.
A 30-year-old man recently emigrated from a highly endemic region presents with a 3-week history of low-grade fever, weight loss, and cranial nerve VI palsy. CSF reveals 300 WBCs/µL (predominantly lymphocytes), glucose 20 mg/dL, and protein 250 mg/dL.

Matches

Show answer & explanation

Answer

The correct pairings match each central nervous system infection's classic clinical phenotype and cerebrospinal fluid profile to its definitive or empiric antimicrobial therapy (bacterial to ceftriaxone/vancomycin, viral HSV to acyclovir, fungal cryptococcal to amphotericin/flucytosine, and mycobacterial to RIPE+steroids).
Each matching pair requires recognizing the classic clinical phenotype and CSF profile of a specific CNS infection to select the correct corresponding antimicrobial therapy. Bacterial meningitis presents with neutrophilic pleocytosis and hypoglycorrhachia. HSV encephalitis typically causes temporal lobe necrosis leading to RBCs in the CSF with a lymphocytic pleocytosis. Cryptococcal meningitis is associated with high opening pressures in immunocompromised hosts. TB meningitis typically presents subacutely with cranial nerve palsies, profound hypoglycorrhachia, and extremely high protein.

Step-by-Step Solution

1
Analyze the CSF profile and clinical presentation for the 22-year-old student.
Identification of a neutrophilic pleocytosis with low glucose and petechial rash, indicative of bacterial meningitis.
This classical presentation dictates immediate empiric therapy with broad-spectrum antibacterials covering S. pneumoniae and N. meningitidis.
2
Evaluate the 65-year-old man with confusion, seizures, and CSF erythrocytes.
Diagnosis of suspected HSV encephalitis, which requires empiric intravenous acyclovir.
Erythrocytes in a lymphocytic, normal-glucose CSF profile strongly suggest the hemorrhagic temporal lobe necrosis typical of HSV.
3
Assess the HIV-positive patient with an extremely high CSF opening pressure.
Diagnosis of cryptococcal meningitis, necessitating induction therapy with amphotericin B and flucytosine.
Cryptococcus uniquely causes severe intracranial hypertension with a mild lymphocytic pleocytosis in immunocompromised hosts.
4
Review the subacute presentation of cranial nerve palsy and highly elevated CSF protein in the immigrant patient.
Diagnosis of tuberculous meningitis, requiring RIPE therapy and dexamethasone.
Basilar exudates causing cranial neuropathies alongside subacute lymphocytic meningitis are the hallmark of CNS tuberculosis.

Key Concept

Cerebrospinal fluid (CSF) analysis interpretation and appropriate empiric therapy for central nervous system infections
Question 109Question →

A 1919-year-old male college student presents to the emergency department accompanied by his roommate after developing a severe headache, confusion, and high fever over the previous 1212 hours. His temperature is 39.6∘C39.6^\circ\text{C} (103.3∘F103.3^\circ\text{F}), blood pressure is 108/68 mmHg108/68\text{ mmHg}, and heart rate is 118 beats/min118\text{ beats/min}. Physical examination reveals marked nuchal rigidity and a non-blanching petechial rash on his lower extremities. A lumbar puncture is performed, and empiric therapy with intravenous ceftriaxone, vancomycin, and dexamethasone is promptly initiated. Cerebrospinal fluid (CSF) analysis shows a leukocyte count of 3,200 cells/mm33,200\text{ cells/mm}^3 (92%92\% neutrophils), a glucose level of 22 mg/dL22\text{ mg/dL}, and a protein level of 165 mg/dL165\text{ mg/dL}. The following day, the patient's mental status improves. CSF culture grows *Neisseria meningitidis*. Antimicrobial susceptibility testing is pending. Which of the following is the most appropriate next step in this patient's antimicrobial management?

Show answer & explanation

Answer: Stop the vancomycin infusion and maintain the ceftriaxone.

Answer

Stop the vancomycin infusion and maintain the ceftriaxone.
The correct answer is to discontinue the vancomycin infusion and maintain the ceftriaxone. Empiric therapy for acute bacterial meningitis in immunocompetent adults between the ages of 22 and 5050 consists of a third-generation cephalosporin (e.g., ceftriaxone or cefotaxime) plus vancomycin. The sole purpose of adding vancomycin to this empiric regimen is to provide adequate coverage against highly penicillin-resistant strains of *Streptococcus pneumoniae*. Once cerebrospinal fluid cultures definitively identify *Neisseria meningitidis*, the risk of resistant *S. pneumoniae* is eliminated. Antimicrobial stewardship principles strongly dictate that broad-spectrum or additional agents should be discontinued (de-escalated) as soon as culture results allow. *N. meningitidis* is highly susceptible to ceftriaxone, which also boasts excellent central nervous system penetration. Therefore, maintaining ceftriaxone and stopping vancomycin is the most appropriate, targeted management.

Step-by-Step Solution

1
Analyze the patient's presentation and initial management.
The patient presented with classic signs of acute bacterial meningitis and was appropriately started on empiric ceftriaxone, vancomycin, and dexamethasone.
Empiric therapy must cover the most likely pathogens, including highly penicillin-resistant Streptococcus pneumoniae (covered by vancomycin) and Neisseria meningitidis (covered by ceftriaxone).
2
Evaluate the new culture data.
CSF culture has isolated Neisseria meningitidis.
Identifying the specific pathogen allows for targeted therapy, optimizing efficacy while minimizing toxicity and resistance.
3
Determine the appropriate modification to the antibiotic regimen based on stewardship principles.
Vancomycin is no longer needed because the pathogen is not S. pneumoniae. Ceftriaxone alone provides reliable coverage for N. meningitidis.
Discontinuing unnecessary broad-spectrum coverage (de-escalation) is a core component of antimicrobial stewardship.

Key Concept

In patients with acute bacterial meningitis, empiric vancomycin is used specifically to cover penicillin-resistant Streptococcus pneumoniae and should be discontinued once a different pathogen, such as Neisseria meningitidis, is identified.
Question 110Question →

A 65-year-old man presents to the outpatient clinic with a 4-day history of a productive cough, fevers, and progressively worsening shortness of breath. His medical history is significant for hypertension and type 2 diabetes mellitus, for which he takes lisinopril and metformin. His temperature is 38.4°C (101.1°F), blood pressure is 132/82 mm Hg, pulse is 98/min, and respiratory rate is 22/min. Pulse oximetry shows an oxygen saturation of 94% on room air. Physical examination reveals bronchial breath sounds and crackles in the right lower lung field. A chest radiograph demonstrates a dense consolidation in the right lower lobe. The physician determines the patient is stable for outpatient management. Which of the following is the most appropriate empiric pharmacotherapy for this patient?

Show answer & explanation

Answer: Amoxicillin-clavulanate and azithromycin

Answer

Amoxicillin-clavulanate and azithromycin
The correct answer provides the recommended combination therapy for an outpatient with community-acquired pneumonia (CAP) who has significant medical comorbidities (such as type 2 diabetes mellitus). According to current clinical guidelines, outpatients with comorbidities (e.g., chronic heart, lung, liver, or renal disease; diabetes mellitus; alcoholism; malignancy; or asplenia) require expanded empiric coverage. This is typically achieved with combination therapy consisting of a beta-lactam (such as amoxicillin-clavulanate or cefpodoxime) PLUS a macrolide (such as azithromycin) or doxycycline. Alternatively, monotherapy with a respiratory fluoroquinolone (such as levofloxacin or moxifloxacin) can be used. The beta-lactam provides robust coverage against typical pathogens (e.g., Streptococcus pneumoniae, Haemophilus influenzae), while the macrolide provides coverage against atypical organisms (e.g., Mycoplasma pneumoniae, Chlamydia pneumoniae).

Step-by-Step Solution

1
Diagnose the patient's condition based on clinical presentation.
The patient has community-acquired pneumonia (CAP), evidenced by fever, productive cough, crackles, and a focal lobar consolidation on chest radiograph.
Establishing the correct infectious syndrome is required before selecting empiric antimicrobial therapy.
2
Stratify the patient's risk and determine the appropriate setting of care.
The patient has stable vital signs and oxygenation, permitting outpatient treatment. However, he has significant comorbidities (type 2 diabetes mellitus, hypertension).
The presence of comorbidities alters the expected pathogen profile and resistance patterns, dictating a different empiric antibiotic strategy compared to healthy individuals.
3
Select the appropriate empiric antibiotic regimen for an outpatient with CAP and comorbidities.
The recommended regimen is a beta-lactam (e.g., amoxicillin-clavulanate) combined with a macrolide (e.g., azithromycin) or doxycycline, OR monotherapy with a respiratory fluoroquinolone.
This strategy ensures adequate coverage against common typical pathogens (including macrolide-resistant Streptococcus pneumoniae and beta-lactamase producing Haemophilus influenzae) as well as atypical pathogens (Mycoplasma, Chlamydia, Legionella).

Key Concept

Empiric antibiotic selection for community-acquired pneumonia (CAP) in outpatients with comorbidities
Question 111Question →

Primary care evaluation is requested for a 52-year-old male reporting four weeks of profound fatigue, night sweats, and unintentional weight loss. The patient underwent an uncomplicated cystoscopy for benign prostatic hyperplasia two months ago. Vital signs include a temperature of 38.2°C (100.8°F), blood pressure of 118/76 mmHg, and a heart rate of 94/min. Physical examination reveals splinter hemorrhages on the bilateral fingernails and a new grade III/VI holosystolic murmur loudest at the cardiac apex. Transesophageal echocardiography demonstrates a 1.4-cm oscillating mass on the anterior leaflet of the mitral valve. Four out of four blood culture bottles grow *Enterococcus faecalis*. Antimicrobial susceptibility testing reveals the following:

AntimicrobialInterpretation
AmpicillinSusceptible
PenicillinSusceptible
VancomycinSusceptible
Gentamicin (High-Level)Resistant
Streptomycin (High-Level)Resistant

Based on the antimicrobial susceptibility results, which of the following is the most appropriate definitive intravenous antibiotic regimen?

Show answer & explanation

Answer: Ampicillin and ceftriaxone

Answer

Ampicillin and ceftriaxone
The correct answer is ampicillin and ceftriaxone. *Enterococcus faecalis* is a classic cause of infective endocarditis following genitourinary manipulation (such as cystoscopy). Successful treatment requires bactericidal activity. Because ampicillin alone is only bacteriostatic against enterococci, it must be combined with a synergistic agent. Historically, synergy was achieved by combining ampicillin with an aminoglycoside (e.g., gentamicin). However, this patient's isolate demonstrates high-level aminoglycoside resistance (HLAR), meaning aminoglycoside-modifying enzymes completely negate any potential synergy.

To achieve bactericidal activity in HLAR *E. faecalis*, a dual beta-lactam regimen of ampicillin and ceftriaxone is utilized. While enterococci are intrinsically resistant to cephalosporins due to low affinity for specific penicillin-binding proteins (PBPs, primarily PBP5), ampicillin effectively binds PBP4 and PBP5, while ceftriaxone binds PBP2 and PBP3. This complementary saturation of PBPs results in a powerful synergistic bactericidal effect. Notably, because of its equivalent efficacy and lack of nephrotoxicity, ampicillin plus ceftriaxone is now widely considered a first-line therapy for all *E. faecalis* endocarditis cases, even in the absence of HLAR.

Step-by-Step Solution

1
Identify the clinical syndrome
The patient has subacute native valve infective endocarditis, likely seeded from a recent genitourinary procedure.
Establishing the diagnosis determines the requirement for prolonged, bactericidal combination antibiotic therapy.
2
Analyze the microbiologic and susceptibility data
The pathogen is *Enterococcus faecalis*. It is susceptible to beta-lactams (ampicillin, penicillin) but demonstrates high-level resistance to both gentamicin and streptomycin.
To select targeted therapeutic options and rule out ineffective combinations.
3
Evaluate standard treatment protocols in the context of resistance
Standard bactericidal therapy for *E. faecalis* endocarditis historically involves ampicillin plus an aminoglycoside. However, high-level aminoglycoside resistance (HLAR) means synergy is lost, making this combination ineffective.
To prevent the administration of toxic and non-synergistic medications.
4
Select the optimal alternative regimen based on stewardship principles
Ampicillin plus ceftriaxone is selected. This dual beta-lactam regimen provides synergistic bactericidal activity independently of aminoglycoside resistance.
To achieve a targeted, curative outcome while minimizing toxicity and avoiding unnecessarily broad antibiotics like daptomycin.

Key Concept

The definitive treatment of *Enterococcus faecalis* infective endocarditis with high-level aminoglycoside resistance (HLAR) requires dual beta-lactam therapy with ampicillin and ceftriaxone to achieve synergistic bactericidal activity.
Question 112Question →

A 6262-year-old man is evaluated in the hospital on hospital day 33. He originally presented with a 22-day history of fever, right flank pain, and dysuria. Medical history is significant for nephrolithiasis, for which he underwent a cystoscopy with stent placement 11 week ago.

On admission, temperature was 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}), blood pressure was 104/62 mmHg104/62\text{ mmHg}, and pulse was 112/min112/\text{min}. Laboratory studies showed a leukocyte count of 16,500/μL16,500/\mu\text{L}. He was empirically started on intravenous piperacillin-tazobactam.

Today (hospital day 33), his temperature is 37.4∘C37.4^\circ\text{C} (99.3∘F99.3^\circ\text{F}), blood pressure is 122/78 mmHg122/78\text{ mmHg}, and pulse is 84/min84/\text{min}. Blood and urine cultures obtained on admission both grow *Enterobacter cloacae*. Antimicrobial susceptibility testing reveals the following:

* Ampicillin: Resistant
* Cefazolin: Resistant
* Ceftriaxone: Susceptible
* Cefepime: Susceptible
* Piperacillin-tazobactam: Susceptible
* Meropenem: Susceptible

Based on these results, which of the following is the most appropriate next step in the patient's antimicrobial management?

Show answer & explanation

Answer: Transition to intravenous cefepime

Answer

The correct answer is to transition the patient to intravenous cefepime.
The correct next step is to transition the patient to intravenous cefepime. *Enterobacter cloacae* is an organism that intrinsically carries an inducible chromosomal *AmpC* beta-lactamase gene. In the setting of a high initial bacterial burden or invasive infection (such as bacteremia), treating this organism with a third-generation cephalosporin (e.g., ceftriaxone) can rapidly select for derepressed mutants that hyperproduce the AmpC enzyme, leading to subsequent clinical failure despite initial in vitro susceptibility. Cefepime, a fourth-generation cephalosporin, is highly stable against AmpC hydrolysis and is a weak inducer of the enzyme. According to current infectious disease guidelines, cefepime is the preferred definitive therapy for susceptible, high-risk AmpC producers. This choice maximizes clinical efficacy while adhering to antibiotic stewardship principles by sparing carbapenems.

Step-by-Step Solution

1
Analyze the clinical scenario and the microbiological data.
The patient has a urinary-source bacteremia caused by *Enterobacter cloacae*. He is clinically improving on empiric therapy, but definitive targeted therapy is now required based on culture susceptibilities.
Establishing the severity (invasive bacteremia) and the specific pathogen dictates the rules of antibiotic stewardship.
2
Identify the specific resistance mechanisms characteristic of the isolated organism.
*Enterobacter cloacae* is a classic high-risk producer of inducible chromosomal AmpC beta-lactamase.
Organisms with AmpC (like Enterobacter, Klebsiella aerogenes, and Citrobacter freundii) can rapidly develop resistance on therapy even if they initially test susceptible to certain antibiotics.
3
Evaluate the treatment options for an AmpC-producing organism.
Third-generation cephalosporins (ceftriaxone) and piperacillin-tazobactam are associated with clinical failure in invasive AmpC infections despite in vitro susceptibility. Cefepime and carbapenems (meropenem) remain clinically active.
Selecting an antibiotic that will not be hydrolyzed by the AmpC enzyme is critical for patient survival.
4
Apply antimicrobial stewardship principles to select the definitive agent.
Cefepime should be selected over meropenem since the isolate is susceptible to cefepime.
Carbapenems should be spared whenever possible to prevent the emergence of carbapenem-resistant Enterobacteriaceae (CRE). Cefepime provides the optimal balance of targeted efficacy and stewardship.

Key Concept

Definitive treatment of invasive infections caused by high-risk AmpC-producing Enterobacterales (e.g., *Enterobacter cloacae*) requires cefepime (when susceptible) to avoid clinical failure and spare carbapenem use.
Question 113Question →

A 68-year-old man is evaluated in the hospital on the third day of his admission for community-acquired pneumonia. He originally presented with a 3-day history of fever, productive cough, and shortness of breath. Chest radiography on admission showed a left lower lobe consolidation. He was empirically started on intravenous ceftriaxone and azithromycin. Today, he reports feeling much better and his cough has improved. He has been afebrile for the past 24 hours. His temperature is 37.1°C (98.8°F), blood pressure is 126/82 mm Hg, heart rate is 78/min, and respirations are 16/min. Pulse oximetry is 96% on ambient air. The patient is tolerating a regular diet. Blood cultures obtained on admission are sterile. Sputum culture has grown heavy *Streptococcus pneumoniae*. Susceptibility testing reveals the isolate is sensitive to penicillin, amoxicillin, ceftriaxone, levofloxacin, and vancomycin. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Switch to oral amoxicillin

Answer

Switch to oral amoxicillin
The correct answer is to switch to oral amoxicillin. This patient was admitted with community-acquired pneumonia and appropriately started on an empiric regimen of intravenous ceftriaxone and azithromycin. By hospital day 3, he has met the criteria for clinical stability (afebrile, normal hemodynamics, tolerating oral intake) and is a candidate for transition to oral therapy. Sputum cultures have identified Streptococcus pneumoniae, a typical bacterial pathogen, rendering continued atypical coverage with azithromycin unnecessary. Furthermore, the isolate is sensitive to penicillin. According to the principles of antimicrobial stewardship, antibiotic therapy should be de-escalated to the narrowest effective agent. Oral amoxicillin is the targeted, narrow-spectrum drug of choice for penicillin-susceptible S. pneumoniae.

Step-by-Step Solution

1
Assess the patient's clinical stability for an intravenous-to-oral transition.
The patient is afebrile for 24 hours, hemodynamically stable, has a normal respiratory rate and oxygen saturation, and is tolerating a regular diet.
Patients hospitalized with community-acquired pneumonia should be transitioned to oral antibiotics as soon as they achieve clinical stability and can safely absorb oral medications, in order to facilitate early discharge and reduce catheter-related complications.
2
Evaluate the definitive microbiology and susceptibility results.
Sputum culture confirms an infection by Streptococcus pneumoniae that is fully sensitive to penicillin and amoxicillin.
Empiric broad-spectrum therapy must be de-escalated to a targeted regimen once the causative pathogen and its susceptibility profile are identified.
3
Select the most appropriate targeted oral antibiotic based on stewardship principles.
Oral amoxicillin is the optimal choice.
Amoxicillin provides excellent, narrow-spectrum coverage for penicillin-susceptible S. pneumoniae. Broad-spectrum agents or beta-lactamase inhibitors are unnecessary and inappropriate.

Key Concept

Patients hospitalized for community-acquired pneumonia should be transitioned from empirical intravenous therapy to targeted, narrow-spectrum oral antibiotics once they demonstrate clinical stability and a susceptible pathogen is identified.
Question 114Question →

A 52-year-old man is evaluated in the hospital for fever. He was admitted 12 days ago for induction chemotherapy to treat acute myeloid leukemia. Two days ago, he developed a fever of 38.8∘C38.8^{\circ}\text{C} (101.8∘F101.8^{\circ}\text{F}). At that time, his blood pressure was 108/68 mm Hg108/68\text{ mm Hg} and pulse was 112/min112/\text{min}. Laboratory studies showed an absolute neutrophil count (ANC) of 80/μL80/\mu\text{L}. Empiric intravenous cefepime and vancomycin were initiated after blood and urine cultures were obtained. Today, the patient reports feeling much better. He has been afebrile for the past 24 hours. His blood pressure is 122/78 mm Hg122/78\text{ mm Hg} and pulse is 84/min84/\text{min}. The central venous catheter site appears clean with no erythema or induration. Today's laboratory results show an ANC of 110/μL110/\mu\text{L}. Blood cultures drawn two days ago are positive for *Escherichia coli*. Susceptibility testing indicates the organism is susceptible to ceftriaxone, cefepime, piperacillin-tazobactam, and ciprofloxacin, and resistant to ampicillin. Which of the following is the most appropriate next step in the management of this patient's antibiotic therapy?

Show answer & explanation

Answer: Discontinue vancomycin and continue cefepime

Answer

Discontinue vancomycin and continue cefepime
The correct action is to discontinue vancomycin and continue cefepime. The patient originally required empiric therapy for febrile neutropenia, which correctly included an anti-pseudomonal beta-lactam (cefepime). Vancomycin was likely added for possible catheter-related infection or initial instability. At 48 hours, blood cultures show only *E. coli*. According to standard guidelines for high-risk febrile neutropenia, empiric vancomycin should be discontinued if no Gram-positive pathogen is identified. However, despite the *E. coli* being susceptible to narrower agents like ceftriaxone, patients who remain profoundly neutropenic (ANC < 500/μL500/\mu\text{L}) must be maintained on an anti-pseudomonal agent (like cefepime, meropenem, or piperacillin-tazobactam) to protect against secondary *Pseudomonas aeruginosa* infections until marrow recovery.

Step-by-Step Solution

1
Identify the primary clinical scenario and patient risk stratification.
The patient has high-risk febrile neutropenia (ANC < 500/μL500/\mu\text{L}, hematologic malignancy undergoing induction) complicated by Gram-negative bacteremia.
Risk stratification determines the necessary breadth and duration of antimicrobial coverage.
2
Evaluate the need for continued Gram-positive (MRSA) coverage.
Vancomycin should be discontinued.
Empiric vancomycin is indicated initially for line-associated infections or hemodynamic instability, but must be stopped at 48 hours if no Gram-positive organisms are isolated to prevent resistance and toxicity.
3
Analyze the appropriate Gram-negative coverage given the culture results.
Although the isolated *E. coli* is susceptible to narrower agents like ceftriaxone, an anti-pseudomonal beta-lactam (cefepime) must be continued.
In high-risk febrile neutropenia, patients remain highly susceptible to fatal secondary infections, including *Pseudomonas aeruginosa*, until their ANC recovers to > 500/μL500/\mu\text{L}. Standard targeted therapy is insufficient; empiric anti-pseudomonal coverage must be maintained simultaneously.

Key Concept

In high-risk febrile neutropenia with a documented non-pseudomonal Gram-negative infection, empiric anti-pseudomonal coverage must be maintained alongside targeted therapy until neutrophil recovery (ANC > 500/μL).
Question 115Question →

A 74-year-old woman is evaluated on postoperative day 3 following a left total knee arthroplasty. Her temperature is 38.1°C (100.6°F), blood pressure is 128/76 mm Hg, pulse is 82/min, and respirations are 14/min. The patient is ambulating with physical therapy and reports that her surgical pain is well controlled. An indwelling urinary catheter, placed during the surgery, was removed yesterday. She denies dysuria, urinary urgency, frequency, and flank pain. Physical examination shows a clean surgical incision without erythema, induration, or purulent drainage. The lungs are clear to auscultation. The calves are soft, non-tender, and symmetric. A urinalysis reveals 25 white blood cells/hpf and is positive for leukocyte esterase and nitrites. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassurance and observation

Answer

Reassurance and observation is the correct management for this patient with asymptomatic bacteriuria and a normal postoperative fever.
The correct answer recommends reassurance and observation. The patient has asymptomatic bacteriuria (ASB), characterized by the presence of bacteria in the urine (suggested by positive nitrites) and pyuria (leukocyte esterase and white blood cells) without localizing signs or symptoms of a urinary tract infection, such as dysuria, frequency, urgency, or flank pain. Furthermore, her mild temperature elevation is a normal physiologic inflammatory response typical in the early postoperative period, often lasting up to 3 to 5 days. ASB is an expected finding following the removal of an indwelling urinary catheter. According to current infectious disease guidelines, ASB should not be screened for or treated with antibiotics except in specific populations, such as pregnant patients and those undergoing endoscopic urologic procedures associated with mucosal trauma. Providing antibiotic treatment for ASB in patients undergoing non-urologic surgery, including orthopedic joint replacement, does not reduce the rate of surgical site infection. Instead, it unnecessarily exposes the patient to adverse drug events, increases the risk of Clostridioides difficile infection, and drives antimicrobial resistance. Therefore, the most appropriate next step in management is observation.

Step-by-Step Solution

1
Evaluate the patient's clinical presentation and timeline.
The patient has a low-grade fever on postoperative day 3, without localized infectious symptoms or signs of deep vein thrombosis.
Mild fever in the early postoperative period (days 1-3) is frequently a normal physiologic inflammatory response rather than an infectious complication.
2
Interpret the urinalysis findings in the context of the patient's symptoms.
The patient has pyuria and bacteriuria but completely lacks urinary symptoms (no dysuria, urgency, or frequency).
The presence of bacteria and white blood cells in the urine without accompanying genitourinary symptoms confirms the diagnosis of asymptomatic bacteriuria, which is highly expected following recent catheter removal.
3
Determine the appropriate management for asymptomatic bacteriuria in this setting.
Antibiotic therapy is appropriately withheld, and the patient is observed.
Screening for or treating asymptomatic bacteriuria is not indicated in most patients (including post-arthroplasty) because it does not improve clinical outcomes and only increases the risk of antimicrobial resistance and adverse drug events.

Key Concept

Asymptomatic bacteriuria diagnosis and antibiotic stewardship
Estimated Time:1m 0s
Question 116Question →

A 65-year-old man is evaluated in the hospital for management of infective endocarditis. He was admitted three days ago after presenting with a one-week history of fevers, severe fatigue, and night sweats. His medical history is significant for hypertension and stage 3a chronic kidney disease with a baseline serum creatinine of 1.6 mg/dL.

Upon admission, multiple sets of blood cultures were obtained, and the patient was started on empiric intravenous vancomycin and piperacillin-tazobactam. Transthoracic echocardiography performed yesterday demonstrated a 1.2-cm mobile vegetation on the anterior leaflet of the native mitral valve.

Today, the microbiology laboratory finalizes the blood culture results, reporting that all four bottles are growing *Enterococcus faecalis*. The isolate is susceptible to ampicillin, vancomycin, gentamicin, and linezolid.

Based on current clinical guidelines, which of the following is the most appropriate definitive antimicrobial regimen for this patient?

Show answer & explanation

Answer: Intravenous ampicillin and intravenous ceftriaxone

Answer

The most appropriate definitive regimen is the combination of intravenous ampicillin and intravenous ceftriaxone.
The correct answer is the combination of intravenous ampicillin and intravenous ceftriaxone. *Enterococcus faecalis* infective endocarditis requires a bactericidal regimen, which is achieved through dual antibiotic therapy. While ampicillin monotherapy is bacteriostatic against enterococci, the addition of a second agent provides synergistic bactericidal activity. Large clinical trials have demonstrated that the combination of ampicillin and ceftriaxone is equally effective as the historical standard (ampicillin plus an aminoglycoside) for treating *E. faecalis* endocarditis, but is associated with a significantly lower risk of nephrotoxicity. This remarkable synergy occurs because ceftriaxone saturates specific penicillin-binding proteins (PBPs) that ampicillin does not effectively target, leading to complete cell wall breakdown despite the organism's intrinsic resistance to cephalosporin monotherapy. Given this patient's pre-existing chronic kidney disease, avoiding nephrotoxic agents like gentamicin is critical, making ampicillin and ceftriaxone the definitive regimen of choice.

Step-by-Step Solution

1
Analyze the microbiological data and diagnosis.
The patient has native valve infective endocarditis caused by ampicillin-susceptible *Enterococcus faecalis*.
Establishing the precise pathogen and its susceptibility profile is required to transition from empiric broad-spectrum therapy to targeted therapy.
2
Determine the pharmacological requirements for treating enterococcal endocarditis.
A synergistic, bactericidal regimen is necessary because beta-lactam monotherapy (like ampicillin alone) is only bacteriostatic against enterococci.
Endocarditis is an endovascular infection with high bacterial density that requires bactericidal action for complete pathogen eradication and clinical cure.
3
Evaluate the patient's comorbidities to select the safest and most effective synergistic regimen.
The patient has stage 3a chronic kidney disease. The combination of ampicillin and ceftriaxone provides the necessary bactericidal synergy without the nephrotoxicity associated with aminoglycosides.
Antibiotic stewardship involves selecting the most effective therapy while actively minimizing adverse effects based on patient-specific physiological factors.

Key Concept

Definitive management of *Enterococcus faecalis* infective endocarditis requires synergistic bactericidal therapy; the combination of ampicillin and ceftriaxone is a first-line regimen that is strongly preferred over ampicillin and gentamicin in patients with baseline renal impairment.
Question 117Question →

A 45-year-old man with newly diagnosed acute myeloid leukemia is hospitalized for induction chemotherapy. On day 10 of his hospital stay, he develops a new-onset fever. He reports feeling mildly fatigued but denies cough, shortness of breath, dysuria, or abdominal pain. Temperature is 38.8°C (101.8°F), blood pressure is 122/78 mm Hg, heart rate is 98/min, and respiratory rate is 16/min. Physical examination reveals clear lungs, normal bowel sounds, and no skin rashes. His totally implantable venous access port in the right upper chest is clean, with no surrounding erythema, induration, or tenderness. Laboratory studies show a leukocyte count of 400/mm³ with an absolute neutrophil count of 100/mm³. Blood and urine cultures are obtained. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Show answer & explanation

Answer: Intravenous cefepime

Answer

Intravenous cefepime
This patient presents with high-risk febrile neutropenia (absolute neutrophil count <500/mm³ and a single oral temperature ≥38.3°C). Because neutropenic patients lack the normal inflammatory response, an occult infection can rapidly progress to life-threatening sepsis. The standard of care for high-risk patients (such as those undergoing induction chemotherapy for leukemia) is immediate empiric monotherapy with an intravenous anti-pseudomonal beta-lactam, such as cefepime, meropenem, or piperacillin-tazobactam. This approach provides excellent coverage against Pseudomonas aeruginosa and other serious gram-negative pathogens, which are the most rapidly lethal organisms in this population.

Step-by-Step Solution

1
Calculate the absolute neutrophil count and identify the clinical syndrome.
The patient has an absolute neutrophil count of 100/mm³ and a fever of 38.8°C (101.8°F), meeting the diagnostic criteria for febrile neutropenia.
Febrile neutropenia is a medical emergency because patients can rapidly deteriorate from overwhelming bacterial sepsis.
2
Stratify the patient's risk level to determine the route and setting of care.
The patient is high-risk because he has profound neutropenia (<100/mm³) expected to last greater than 7 days due to AML induction chemotherapy.
High-risk patients require hospital admission and prompt administration of intravenous broad-spectrum antibiotics.
3
Select the appropriate empiric antimicrobial coverage, specifically targeting Pseudomonas aeruginosa.
Intravenous cefepime (or piperacillin-tazobactam, or a carbapenem) is selected as monotherapy.
Empiric therapy must cover gram-negative organisms, particularly Pseudomonas aeruginosa, which can cause rapidly fatal infections in neutropenic hosts.
4
Evaluate the need for empiric Gram-positive coverage (MRSA) with vancomycin.
Vancomycin is deferred because the patient lacks specific indications.
According to IDSA guidelines, empiric vancomycin should only be added for hemodynamic instability, clinically suspected catheter-related infection (erythema/purulence), skin/soft tissue infection, severe mucositis, or known MRSA colonization.

Key Concept

High-risk febrile neutropenia requires immediate empiric intravenous monotherapy with an anti-pseudomonal beta-lactam (e.g., cefepime). Routine upfront addition of vancomycin is not indicated unless specific risk factors (e.g., hypotension, overt catheter-site infection) are present.
Question 118Question →

An elderly male patient, aged 72, comes to the clinic reporting a four-week history of profound fatigue, night sweats, and unintentional weight loss. He notes that these symptoms began roughly two weeks after he underwent a transurethral resection of the prostate for benign prostatic hyperplasia. His temperature in the clinic is 38.2°C (100.8°F), blood pressure is 134/68 mm Hg, and pulse is 96/min. Cardiovascular auscultation reveals a new early diastolic decrescendo murmur best heard at the left third intercostal space. Physical examination also demonstrates nontender, erythematous macules on the palms and soles. Transesophageal echocardiography confirms a mobile, 1.1-cm vegetation on the right coronary cusp of the aortic valve. Two days later, all three sets of blood cultures are positive for *Enterococcus faecalis*. Antimicrobial susceptibility testing indicates that the isolate is susceptible to ampicillin and vancomycin. However, high-level resistance to both gentamicin and streptomycin is detected. Renal function is within normal limits. Which of the following is the most appropriate definitive intravenous antibiotic regimen for this patient?

Show answer & explanation

Answer: Ampicillin and ceftriaxone

Answer

Ampicillin and ceftriaxone
The correct answer is ampicillin and ceftriaxone. Enterococcal endocarditis requires bactericidal therapy, but beta-lactams alone are only bacteriostatic against these organisms. While the classic synergistic regimen is ampicillin plus gentamicin, the presence of high-level aminoglycoside resistance (HLAR) abolishes this synergy. In cases of HLAR, the standard of care is a dual beta-lactam regimen of ampicillin and ceftriaxone. Although enterococci are intrinsically resistant to cephalosporins, ceftriaxone works synergistically with ampicillin by saturating complementary penicillin-binding proteins (PBPs), resulting in highly effective bactericidal activity while avoiding aminoglycoside toxicity.

Step-by-Step Solution

1
Identify the primary clinical syndrome and causative organism.
The patient has subacute infective endocarditis (new murmur, Janeway lesions, positive echo) caused by Enterococcus faecalis, likely seeded during his recent genitourinary surgery.
Establishing the diagnosis and pathogen is the first prerequisite for tailoring antimicrobial therapy.
2
Determine the pharmacological requirements for treating this specific infection.
Endocarditis requires bactericidal therapy to sterilize the heart valve. Because cell-wall active agents (like ampicillin) are only bacteriostatic against Enterococcus, a second agent is needed to achieve bactericidal synergy.
Monotherapy with beta-lactams is insufficient for curing enterococcal endocarditis.
3
Analyze the susceptibility data provided.
The isolate has high-level aminoglycoside resistance (HLAR). This means that adding an aminoglycoside (like gentamicin or streptomycin) will not result in bactericidal synergy and will only cause toxicity.
Identifying HLAR explicitly rules out the traditional ampicillin plus gentamicin regimen.
4
Select the appropriate alternative synergistic regimen.
The combination of ampicillin and ceftriaxone is selected. This dual beta-lactam therapy provides bactericidal synergy against E. faecalis.
Ceftriaxone saturates peripheral penicillin-binding proteins (PBP2, PBP3), while ampicillin saturates the remaining PBPs (PBP4, PBP5), working together to effectively kill the bacteria without requiring an aminoglycoside.

Key Concept

Management of Enterococcus faecalis infective endocarditis with high-level aminoglycoside resistance (HLAR) requires dual beta-lactam therapy (ampicillin and ceftriaxone) to achieve bactericidal synergy.
Estimated Time:2m 0s
Question 119Question →

A 64-year-old woman is brought to the emergency department by her husband due to rapidly progressive confusion and a severe headache over the past 14 hours. She has a history of a deceased-donor renal transplant performed three years ago and is currently maintained on a regimen of tacrolimus, mycophenolate mofetil, and low-dose prednisone. On arrival, her temperature is 39.4°C (102.9°F), blood pressure is 98/60 mmHg, heart rate is 118/min, and respiratory rate is 24/min. Physical examination demonstrates marked nuchal rigidity. She is lethargic, oriented only to person, and withdraws appropriately from painful stimuli. Pupils are equal and reactive to light.

Arrange the following diagnostic and therapeutic steps in the most appropriate sequential order for the immediate management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first obtain peripheral blood cultures, immediately administer empiric antibiotics and corticosteroids, then perform a non-contrast head CT, and finally perform a lumbar puncture.
In patients with suspected bacterial meningitis who have contraindications to immediate lumbar puncture (e.g., altered mental status, new-onset seizures, focal neurologic deficits, age >60, or an immunocompromised state), the exact sequence of interventions is critical for survival. First, peripheral blood cultures must be drawn to maximize diagnostic yield. Immediately afterward, empiric antibiotics and dexamethasone must be administered. In this immunocompromised patient, the correct regimen includes ceftriaxone, vancomycin, and ampicillin (to cover Listeria monocytogenes). Life-saving therapy must NEVER be delayed for neuroimaging. After therapy is initiated, a non-contrast head CT is performed to rule out mass effect. Only after the CT confirms the absence of mass effect is a lumbar puncture performed for cerebrospinal fluid analysis.

Step-by-Step Solution

1
Recognize the clinical syndrome and assess indications for neuroimaging.
The patient has acute bacterial meningitis. Her immunocompromised state and altered mental status are absolute indications for obtaining a head CT before a lumbar puncture.
Performing a lumbar puncture blindly in a patient with potential elevated intracranial pressure can precipitate fatal cerebral herniation.
2
Sequence the most urgent therapeutic interventions.
Blood cultures are drawn first, followed immediately by empiric intravenous dexamethasone, ceftriaxone, vancomycin, and ampicillin.
Blood cultures must be obtained before antimicrobial administration to optimize pathogen recovery. However, antibiotics must not be delayed while waiting for a CT scan or lumbar puncture; early administration is the most important factor in reducing mortality. Ampicillin is included to cover Listeria monocytogenes due to her immunocompromised status.
3
Sequence the diagnostic neuroimaging and fluid analysis.
A non-contrast head CT is performed next, followed by a lumbar puncture.
The CT scan is necessary to rule out mass effect. Once safety is confirmed by the imaging, the lumbar puncture is performed to obtain cerebrospinal fluid for definitive diagnosis and antimicrobial tailoring.

Key Concept

Management sequence of acute bacterial meningitis in patients with contraindications to immediate lumbar puncture
Estimated Time:1m 30s
Question 120Question →

An antimicrobial stewardship team is auditing the appropriateness of targeted therapies for various complex infections. Match each specific patient scenario and pathogen profile below with its single most appropriate targeted treatment strategy based on current clinical guidelines.

Click a left item, then click its matching right item

Items

A 29-year-old pregnant woman at 24 weeks gestation with secondary syphilis and a documented IgE-mediated anaphylaxis to penicillin.
A 62-year-old man with native valve endocarditis due to Enterococcus faecalis that is ampicillin-susceptible but exhibits high-level gentamicin resistance.
A 68-year-old man with Listeria monocytogenes meningitis and a documented history of severe anaphylaxis to all beta-lactam antibiotics.
A 54-year-old woman with profound neutropenia presenting with pleuritic chest pain; chest imaging reveals a nodule with a surrounding ground-glass halo, and serum galactomannan is markedly elevated.

Matches

Show answer & explanation

Answer

Each clinical scenario is matched with its definitive guideline-recommended targeted therapy, factoring in specific resistance patterns, allergies, and patient characteristics.
Each matching pair correctly aligns a complex infectious disease scenario with its definitive, guideline-supported treatment exception. The pregnant patient with syphilis requires penicillin desensitization. The patient with HLAR Enterococcus endocarditis requires dual beta-lactam therapy (ampicillin and ceftriaxone). The penicillin-allergic patient with Listeria requires trimethoprim-sulfamethoxazole. The patient with invasive aspergillosis requires voriconazole.

Step-by-Step Solution

1
Evaluate the syphilis patient who is pregnant and has a penicillin allergy.
Identify that penicillin is mandatory to prevent congenital syphilis, requiring desensitization.
Alternative treatments are either harmful to the fetus or do not achieve adequate transplacental levels.
2
Evaluate the patient with E. faecalis endocarditis and high-level aminoglycoside resistance (HLAR).
Identify ampicillin plus ceftriaxone as the appropriate regimen.
HLAR precludes the use of gentamicin for synergy; dual beta-lactam therapy is the proven synergistic alternative.
3
Evaluate the patient with Listeria meningitis and a severe beta-lactam allergy.
Identify trimethoprim-sulfamethoxazole as the treatment of choice.
Listeria is intrinsically resistant to cephalosporins, and alternative agents like vancomycin are ineffective. TMP-SMX is bactericidal and penetrates the CSF well.
4
Evaluate the neutropenic patient with a halo sign on chest CT and positive galactomannan.
Identify voriconazole as the appropriate treatment.
The findings are pathognomonic for invasive pulmonary aspergillosis, for which voriconazole is the first-line agent.

Key Concept

Targeted antimicrobial therapy for complex systemic infections requires specific deviations from standard therapy based on patient factors (e.g., pregnancy, severe allergies) and specific pathogen resistance mechanisms.
Estimated Time:2m 0s
PreviousPage 6 / 26Next
Infectious Diseases Practice Questions — USMLE Step 2 CK — Page 6 | Examkin